Billionaire Louis Bacon’s Latest Stock Picks

Louis Bacon manages about $15 billion at Moore Capital Management, and his net worth has been estimated at $1.5 billion. According to Moore’s 13F for the third quarter of the year, Bacon and his team moved heavily into financials between July and September- its five largest long stock positions at the end of the quarter were all in financials and had all been initiated in the last three months. Read on for our quick take on Bacon’s favorite stocks and see what other stocks he liked.

MOORE GLOBAL INVESTMENTS

The largest of these positions according to the 13F was Moore’s 5.3 million shares of Citigroup Inc. (NYSE:C). Citi’s stock price is up 40% in the last year, but the climb in the bank’s valuation relative to the book value of its equity hasn’t been as great: the P/B is still at 0.6. There are a number of factors going into this: exposure to Europe, the perception that Citi is “too big” in the sense of having too many disparate businesses, and the fact that that revenue fell 36% last quarter versus a year earlier, pulling earnings down at an even faster rate. The book value and the forward P/E of 8 indicate that it is a good deal anyway, and we’re interested in the stock. 93 hedge funds and other notable investors owned Citi at the end of September, placing it on our list of the most popular stocks among hedge funds.

JPMorgan Chase & Co. (NYSE:JPM) was another of Moore’s top picks as the fund owned 3.8 million shares of that bank. JPMorgan Chase is generally considered to be a more focused and safe bank than Citi, and the stock has rallied nicely from the London Whale losses earlier this year. Earnings have been up strongly, but in terms of valuation we think that it still looks cheap. JPMorgan Chase trades at 9 times trailing earnings and 8 times forward earnings estimates, not to mention a substantial discount to the bank’s book value (the P/B is 0.8). Billionaire Ken Fisher’s Fisher Asset Management more than doubled its stake in JPMorgan Chase during the third quarter (see more stock picks from Fisher Asset Management).

The fund also liked growing hedge fund favorite American International Group, Inc. (NYSE:AIG). The insurer is yet another stock trading at a low P/B ratio (0.5 in this case) and a reasonable forward P/E (9x). Again, we think that we’d recommend AIG as a value play- it probably shouldn’t be trading at book value as we are skeptical that the company is appropriately valuing its assets, but we think that we should see that ratio creeping up in the coming months and likely doing so through an increase in the stock price.

Moore reported owning 3.1 million shares of U.S. Bancorp (NYSE:USB), a large Midwest-focused bank. It’s a bit more expensive in terms of its financials than the other top picks we’ve discussed. It actually trades at 1.8 times the book value of its equity and at 11 times consensus earnings for 2013. The case for buying in at U.S. Bancorp likely depends on its steady growth in earnings per share, as EPS has increased on a q/q basis each of the three quarters of this year. It’s less of a buy than these other companies from our perspective.

The fund’s 2 million shares of Wells Fargo & Company (NYSE:WFC) made that the fifth largest long stock position reported in the filing. Wells Fargo, like U.S. Bancorp, is generally thought of a safer and more stable bank. It too trades at a premium to the book value of its equity, but a lower one at a P/B ratio of 1.2. Its revenue and earnings grew at double-digit rates in the third quarter compared to the same period in 2011, and its forward P/E is only 9. We think that it’s a better value than U.S. Bancorp and is at least competitive with the cheaper finance and insurance stocks as well.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!